RNS Number:6597L
Pall Corporation
5 June 2000


For More Information Contact:
Patrice Radowitz, Pall Corporation
(516) 484-3600, ext 6111

 
               Mark Sutter Named to Head Critical Filtration Group

East Hills, NY (05/30/2000) -- Eric Krasnoff, Chairman and CEO of Pall
Corporation (NYSE: PLL) has announced the promotion of Mark Sutter, 39, to Vice
President of Pall and President of its newly formed Critical Filtration Group.
This group includes Pall's Laboratory, Medical OEM, Critical Care and Specialty
Materials business units. These divisions contributed approximately $200 million
of the Pall's fiscal 1999 revenues of $1.1 billion.

The businesses for which Mr. Sutter has global responsibility serve many
critical filtration requirements of the health care industry. This begins with
products used by laboratories involved in drug discovery and development, by
producers of rapid diagnostic tests, DNA screening and genomic platforms, and
culminates with point of use filters and delivery systems that are used to
administer drugs to patients. Together with the BioPharmaceuticals part of the
Health Care business, Pall is the only company that satisfies the full spectrum
of filtration requirements of the health care industry from lab bench to
hospital bedside. Overall, the Health Care business represents an $8 billion
opportunity, almost half of the company's current market potential

Mr. Sutter has been with Pall for 14 years, beginning as an R&D engineer and
working up to Vice President of R&D. He transitioned into sales and marketing
positions and for the past five years has been General Manager for the Company's
Critical Care division. Mr. Sutter holds an MBA and a Masters in Bioengineering
from the University of Michigan and a BS in Chemistry and BioMedicine from
Western Michigan University.

Pall is the broadest-based filtration, separations and purification company in
the world and serves more markets with more proprietary products than any other
company in the $18 billion filtration industry. With annual sales of over $1
billion, Pall Corporation is based in East Hills, New York, USA and operates
directly in 30 countries. The Company provides innovative solutions to complex
filtration and separations problems in four major markets: Medical,
BioPharmaceuticals, Aeropower and Industrial Fluid Processing. The Company's
shares are listed on the New York Stock Exchange (PLL). Further information is
available on the Company's web site at http://www.pall.com.

END


APPFGGGVNKKGGZG
Equatorial Palm Oil (LSE:PAL)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Equatorial Palm Oil Charts.
Equatorial Palm Oil (LSE:PAL)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Equatorial Palm Oil Charts.